Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.
暂无分享，去创建一个
T. Merchant | A. Srinivasan | G. Armstrong | J. Gurney | J. A. Heath | C. Wetmore | M. Chintagumpala | A. Gajjar | E. Bouffet | R. Cohn | C. Stewart | M. Fisher | I. Qaddoumi | A. Onar-Thomas | S. Gururangan | T. Hassall | S. Kellie | A. Broniscer | Jie Huang | J. Bass | A. P. Panandiker